FUNDED RESEARCH FOR 2024-2025

APDA-Funded Research for 2024-2025

Exciting research is underway. Take a look at the innovative projects and inspiring researchers APDA is supporting this year.

George C. Cotzias Fellowship

The George C. Cotzias Fellowship is named in honor of the scientist who had a critical role in developing Levodopa as a treatment for Parkinson’s disease and is awarded with the purpose of encouraging young neurologists to follow in his footsteps.


Gary Ho, MD, PhD

Brigham and Women’s Hospital/Harvard Medical School, Boston, MA

Leveraging protein palmitoylation to correct vesicle trafficking defects in Parkinson’s disease

Krithi Irmady, MD, PhD

Rockefeller University, New York City, NY

RNA regulation in Parkinson’s disease and levodopa-induced dyskinesia


Diversity in Parkinson’s Disease Research Grant

The Diversity in Parkinson’s Disease Research Grant is awarded to investigators studying the health disparities or differences among under-represented PD communities.

Melissa Nirenberg, MD, PhD

Bronx Veterans Medical Research Foundation, New York City, NY

Parkinson’s disease phenotype in Black and Hispanic veterans 

Danielle Shpiner, MD

Miller School of Medicine of the University of Miami. Miami, FL

Improving access to advance care planning for Hispanic people with Parkinson’s disease


Post-Doctoral Fellowships

This fellowship is awarded to support post-doctoral scientists whose research holds promise to provide new insights into the pathophysiology, etiology, and treatment of PD.

Abdulmunaim Eid, MD

Washington University, St. Louis, MO

The neurobiological basis of Parkinson’s disease clinical subtypes

Yuxiao Ning, PhD

The Regents of the University of Minnesota, Twin Cities, MN

Multiregional neural population dynamics in
Parkinson’s disease and during directional deep brain stimulation

Brianne Rogers, PhD

HudsonAlpha Institute for Biotechnology, Huntsville, AL 

Mechanisms of SNCA regulation 

Dr. Hanna Sas-Nowosielska, PhD

University of Pennsylvania, Philadelphia, PA

Enhancing neuronal resilience to neurodegeneration via the epigenetic-metabolic axis

Carlos Soto-Faguás, PhD

Oregon Health & Science University, Portland, OR

The effects of the ApoE Christchurch variant on Lewy body pathology development and spreading

Donghe Yang, PhD

Memorial Sloan Kettering Cancer Center, New York City, NY 

Characterizing and modeling the development of human A9 midbrain dopaminergic neurons with pluripotent stem cells


Research Grants

This grant is awarded to investigators performing innovative PD research at major academic institutions across the United States.

Patricia Aguilar Calvo, PhD

University of Alabama at Birmingham, Birmingham, AL 

Heparan-sulfate mediated mechanisms of a-synuclein propagation in Parkinson’s disease  

Athanasios Alexandris, MD

Johns Hopkins University School of Medicine, Baltimore, MD

Investigating the role of a-synucleinopathy in axonal protein homeostasis and viability 

Helen Hwang, MD, PhD

Washington University School of Medicine, St Louis, MO

Characterization of inhibitors of alpha-synuclein fibril growth 

Francesca Magrinelli, MD, PhD

University College London Institute of Neurology, London, UK

Dissecting PSMF1 as a new gene for early-onset Parkinson’s disease/parkinsonism 

Franchino Porciuncula, PT, DScPT, EdD

Trustees of Boston University, Boston, MA

Does rhythmic auditory stimulus reduce the cognitive demands of walking in Parkinson’s disease? 

Emily Rocha, PhD

University of Pittsburgh, Pittsburgh, PA

Lysosomal dysfunction in Parkinson’s disease 

Mariangela Scarduzio, PhD

University of Alabama at Birmingham, Birmingham, AL

Striatal acetylcholine dynamics in L-DOPA-induced dyskinesia 


IN THE NEWS

APDA Awards $2.6 million in Research Grants. 

Click here to read the Press Release